Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Korea Otsuka Pharmaceutical Co., Ltd.

Home Clinical Trial Sponsors and OrganizationsKorea Otsuka Pharmaceutical Co., Ltd.

Korea Otsuka Pharmaceutical Co., Ltd.

ACTIVE

226 Yeoksam-ro, Gangnam-gu, Seoul, South Koreawww.otsuka.co.krSubsidiary

Part of OTSUKA PHARMACEUTICAL CO., LTD.

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

42

2 active

Approvals

15

Total approvals

Agencies

1

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 4

12

28.6%

Phase 3

8

19.1%

Phase 1

7

16.7%

Phase 2

3

7.1%

Trial Status Distribution

Active, not recruiting

1

2.4%

Completed

33

78.6%

Not yet recruiting

1

2.4%

Recruiting

2

4.8%

Terminated

3

7.1%

Unknown

2

4.8%

Clinical Trials

Trials sponsored by this organization (42)

Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)

Not yet recruiting

Nov 2024222 participants

Post-Marketing Surveillance of Safety and Effectiveness of Mucosta®SR Tab.

Oct 2021600 participants

A Study to Evaluate the Efficacy and Safety of MCT-SR in Patients With Gastritis

Dec 2019392 participants

To Evaluate Food Effect on the Pharmacokinetics of Rebamipide in Healthy Volunteers

Jul 201924 participants

Evaluating the Safety and effectivenesS in Adult KorEaN Patients Treated With Tolvaptan for Management of Autosomal domInAnt poLycystic Kidney Disease

Jul 2019118 participants

To Evaluate Pharmacokinetics and Safety of Two Different Formulation of Rebamipide in Healthy Volunteers

Apr 201940 participants

Iclusig PMS in CML or Ph+ALL Patients

Active, not recruiting

Aug 201850 participants

A Study of Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar Depression

Feb 2018390 participants

Page 1 of 6

Approvals

Approvals by Agency

PHILIPPINES

Philippines FDA

15

Approvals

Recent Approvals

Abilify Discmelt

Abilify Discmelt

Abilify Discmelt

Abilify Discmelt

News

No news articles found

On this page

Overview
Clinical Trials42
Approvals15
News

Back to Organizations